Cambridge Drug Discovery Ltd.
This article was originally published in Start Up
Cambridge Drug Discovery was formed in 1997 by four Pfizer scientist who wanted to exploit expertise in assay development, high-throughput screening and informatics, to accelerate the drug discovery process. One of the company's discovery platforms is used to discover small-molecule modulators of G-Protein Coupled Receptors.
You may also be interested in...
The approval is based on the results ABRE clinical study, which showed the stent improved patency iliofemoral veins in 88% of cases with a 2% rate of major adverse events.
Reporting its first full quarter of financials since merging with Allergan, AbbVie will be scrutinized for whether its optimistic talk of a quick Botox rebound actually happened.
Generic OTC paracetamol and ibuprofen pack prices are gradually returning to pre-COVID levels, according to market analysts Wavedata. But a second wave could drive prices back up again.